Search research articles
Contact Us
Filters
Showing results (161-170 of 223) with videos related to
Page
of 23
Sort By:
Drug Discovery Today
|
November 24, 2018
Advancing nonclinical innovation and safety in pharmaceutical testing
Elizabeth J Baker, Nancy A Beck, Ellen L Berg, et al.
JAMA Oncology
|
February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial
Deborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
The Journal of Pathology
|
December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
Brennan T Flannery, Howard M Sandler, Priti Lal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Nature
|
May 23, 2000
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
J B Davis, J Gray, M J Gunthorpe, et al.
Advances in Radiation Oncology
|
November 2, 2019
Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
Joseph A Bovi, Stephanie L Pugh, David Sabsevitz, et al.
Cancers
|
June 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413
Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2021
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004
Debra L Barton, Stephanie L Pugh, Patricia A Ganz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 223) with videos related to
Sort By:
Page
of 23
Drug Discovery Today
|
November 24, 2018
Advancing nonclinical innovation and safety in pharmaceutical testing
Elizabeth J Baker, Nancy A Beck, Ellen L Berg, et al.
JAMA Oncology
|
February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial
Deborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
The Journal of Pathology
|
December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
Brennan T Flannery, Howard M Sandler, Priti Lal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Nature
|
May 23, 2000
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
J B Davis, J Gray, M J Gunthorpe, et al.
Advances in Radiation Oncology
|
November 2, 2019
Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
Joseph A Bovi, Stephanie L Pugh, David Sabsevitz, et al.
Cancers
|
June 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413
Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2021
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004
Debra L Barton, Stephanie L Pugh, Patricia A Ganz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Page
of 23